ArTS Archivio della ricerca di Trieste

FANIN, RENATO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.005
AS - Asia 2.486
EU - Europa 1.398
SA - Sud America 412
AF - Africa 159
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 9.462
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.931
SG - Singapore 1.116
SE - Svezia 431
CN - Cina 362
HK - Hong Kong 336
BR - Brasile 314
VN - Vietnam 299
FR - Francia 145
IT - Italia 138
RU - Federazione Russa 120
KR - Corea 119
PL - Polonia 113
DE - Germania 96
MA - Marocco 96
BG - Bulgaria 85
IE - Irlanda 83
GB - Regno Unito 64
IN - India 62
CA - Canada 44
AR - Argentina 34
BD - Bangladesh 33
MX - Messico 20
TR - Turchia 20
UA - Ucraina 20
ZA - Sudafrica 20
FI - Finlandia 19
IQ - Iraq 19
ID - Indonesia 18
EC - Ecuador 17
BE - Belgio 16
ES - Italia 15
NL - Olanda 15
JP - Giappone 14
PK - Pakistan 13
CO - Colombia 10
SN - Senegal 10
CL - Cile 9
JO - Giordania 9
AE - Emirati Arabi Uniti 8
AT - Austria 7
CH - Svizzera 7
DZ - Algeria 7
EG - Egitto 7
KE - Kenya 7
NP - Nepal 7
PY - Paraguay 7
BO - Bolivia 6
CZ - Repubblica Ceca 5
ET - Etiopia 5
LT - Lituania 5
PE - Perù 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
VE - Venezuela 5
IL - Israele 4
UY - Uruguay 4
HU - Ungheria 3
JM - Giamaica 3
MN - Mongolia 3
OM - Oman 3
PH - Filippine 3
RO - Romania 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TW - Taiwan 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
GA - Gabon 2
IR - Iran 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
MY - Malesia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BS - Bahamas 1
BT - Bhutan 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GY - Guiana 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RS - Serbia 1
YT - Mayotte 1
Totale 9.462
Salva come PNG Salva come JPEG
Città #
Singapore 809
Ashburn 669
Fairfield 615
Hong Kong 333
San Jose 304
Woodbridge 277
Chandler 257
Wilmington 242
Houston 239
Seattle 239
Cambridge 207
Princeton 166
Boardman 153
Beijing 140
Ann Arbor 137
Seoul 115
Ho Chi Minh City 106
Santa Clara 102
Chicago 90
Lauterbourg 89
Casablanca 88
Jacksonville 86
Sofia 84
Dublin 83
Zgierz 81
Columbus 77
The Dalles 59
Los Angeles 58
Hanoi 56
Moscow 51
Milan 44
San Diego 44
Dallas 43
Frankfurt am Main 33
São Paulo 33
Hefei 31
New York 30
Warsaw 28
Düsseldorf 24
Orem 19
Da Nang 17
Montreal 16
Brussels 15
Buffalo 14
Helsinki 14
Trieste 14
Chennai 13
Johannesburg 13
Miano 13
Norwalk 13
London 12
Tokyo 12
Phoenix 11
Toronto 11
Brooklyn 10
Dakar 10
Munich 10
Rio de Janeiro 10
Washington 10
Bremen 9
Haiphong 9
Poplar 9
Redondo Beach 9
Amman 8
Atlanta 8
Campinas 8
Can Tho 8
Portsmouth 8
Andover 7
Mexico City 7
Monmouth Junction 7
Stockholm 7
Tianjin 7
Baghdad 6
Bern 6
Biên Hòa 6
Boston 6
Curitiba 6
Fremont 6
Lahore 6
Nanjing 6
Pune 6
Santiago 6
Shanghai 6
Ankara 5
Augusta 5
Belo Horizonte 5
Cairo 5
Charlotte 5
Council Bluffs 5
Guangzhou 5
Guayaquil 5
Kocaeli 5
Manchester 5
Mumbai 5
Nairobi 5
Raleigh 5
Vienna 5
Addis Ababa 4
Bexley 4
Totale 6.834
Salva come PNG Salva come JPEG
Nome #
Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma 177
Efficacy and safety of rituximab in type II mixed cryoglobulinemia 175
Low-dose rituximab in adult patients with primary immune thrombocytopenia 174
Bendamustine in chronic lymphocytic leukemia: Outcome according to different clinical and biological prognostic factors in the everyday clinical practice 170
Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases 168
Efficacy of selective B cell Blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells 161
Bendamustine salvage therapy for T cell neoplasms 157
Acute hepatic failure as onset of progressive sclerodermatous chronic graft-versus-host disease after donor lymphocyte infusion 157
Rituximab for the treatment of type II mixed cryoglobulinemia 156
B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia 156
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia 156
CHOP-rituximab with pegylated liposomal doxorubicin for the treatment of elderly patients with diffuse large B-cell lymphoma 155
Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation 154
Activity of all-trans-retinoic acid in a case of central nervous system extramedullary relapse of acute promyelocytic leukemia 154
Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results 151
The genotype of the hepatitis C virus in patients with HCV-related B cell non-Hodgkin's lymphoma 151
Prognostic significance of delayed thrombocytopenia after allogeneic stem cell transplant 149
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 149
Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response 148
B-cell compartment as the selective target for the treatment of immune thrombocytopenias 146
Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab 145
Management of immune thrombocytopenia in elderly patients 145
Autologous stem cell transplantation for Hodgkin's lymphoma: results and prognostic factors in 51 high-risk patients 145
Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia 142
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: correlations with clinicobiologic parameters 138
Surgical staging in Hodgkin's disease: the role of laparoscopic splenectomy 138
Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma 137
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia 136
T-cell chimerism and clinical outcome after reduced-intensity conditioning allogeneic stem cell transplantation 135
Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation 126
A retrospective analysis of 144 patients with aggressive non-Hodgkin's lymphoma: impact of aurtologoaus stem cell transplantation in first remission on autcome 126
Rituximab in a case of cold agglutinin disease 125
CD38, BCL-2, PD-1 and PD-1L expression in nodal peripheral T-cell lymphoma (PTCL): Possible biomarkers for novel targeted therapies? 124
Brentuximab vedotin in combination with extended field radiotherapy as salvage treatment for primary refractory Hodgkin lymphoma 122
Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura 122
BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine 122
Earlier administration of Rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia 120
Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin’s lymphomas 120
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 118
High-dose therapy in multiple myeloma: effect of positive selection of CD34+ peripheral blood stem cells on hematologic engraftment and clinical outcome 117
Clinical features and outcome of multiple myeloma arising from the transformation of a monoclonal gammapathy of undetermined significance 117
Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: A phase II clinical trial of the fondazione italiana linfomi 114
Treatment of refractory chronic GVHD with rituximab: a GITMO study 110
Granulocyte colony-stimulating factor (G-CSF) allows the delivery of effective doses of CHOP and CVP regimens in non-Hodgkin lymphomas 109
Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: Results of a retrospective, observational GIMEMA study 108
Paraneoplastic cerebellar degeneration associated with anti-neuronal anti-Tr antibodies in a patient with Hodgkin's disease 107
Intensified full-dose induction therapy (HD-MACHOP+radiotherapy) follwed dy consolidation with BAVC regimen and autologous stem cell transplantation as fron-line therapeutic approach for high risk aggressive non Hodgkin lymphoma 106
New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment? 106
Predicting lymphoma in Sjögren's syndrome and the pathogenetic role of parotid microenvironment through precise parotid swelling recording 104
Nocardiosis with favourable clinical outcome in progressive B-chronic lymphocytic leukaemia 104
Long-lasting complete remission of hepatitis C virus (HCV) infection and HCV-associated immunocytoma with alpha-interferon treatment 104
Endogenous endophthalmitis following disseminated fungemia due to Fusarium solani in a patient with acute myeloid leukemia 102
Risk of C virus infection in Waldenstrom’s syndromes and monoclonal gammopathies 102
Computed tomography, magnetic resonance and gallium 67 scintigraphy for the imaging of residual lymphoma 101
Meningeal and cerebral involvement in multiple myeloma patients 101
The role of granulocyte colony-stimulating factor (filgrastim) in maintaining dose intensity during conventional-dose chemotherapy with ABVD in Hodgkin's disease 101
High-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's lymphoma: a single center experience 98
Prevalence of Hepatitis C Virus infection in patients with lymphoproliferative disorder 98
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi 97
The therapy of primary adult systemic CD30-positive anaplastic large cell lymphoma: results of 40 cases treated in a single center 96
Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults 93
Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients 92
Retrospective analysis of 23 cases with peripheral T-cell lymphoma, unspecified: clinical characteristics and outcome 90
Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult: sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous bone marrow transplantation 90
Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma 89
Hepatitis C virus infection (and additional neoplasms) among marginal zone lymphomas 88
The role of Rituximab in the therapy of mixed cryoglobulinemia 87
Hepatitis C virus and lymphoproliferative disorders 86
The F-MACHOP regimen in the treatment of aggressive non-Hodgkin’s lymphomas: a single centre experience in 72 patients 86
Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas 84
Two cases of concomitant diffuse large B-cell lymphoma and myelodysplastic syndrome 80
Myasthenia gravis after allogeneic bone marrow transplantation: a case report 80
No evidence for B-cell clonality by spectratyping analysis in patients with idiopathic thrombocytopenic purpura undergoing rituximab therapy” 79
Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome 76
Neutralizing anti-interferon-alpha antibodies and response to treatment in patients with Ph+ chronic myeloid leukaemia sequentially treated with recombinant (alpha 2a) and lymphoblastoid interferon-alpha 76
Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab 74
Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies 74
Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantation 71
Retrospective analysis of 34 cases of hairy cell leukemia treated with interferon-alpha and/or 2-chlorodeoxyadenosine 70
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers 70
The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery 69
Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study 62
Myasthenia gravis after allogeneic bone marrow transplantation. A case report and a review of the literature 53
Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous transplantation 52
Early chemosensitivity to VAD regimen predicts a favorable outcome after autologous stem cell transplantation in multiple myeloma 49
Totale 9.772
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.474
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021349 0 0 0 0 0 0 0 0 0 102 66 181
2021/2022937 17 106 2 131 4 23 49 32 113 73 38 349
2022/2023971 117 127 102 60 101 191 1 104 114 17 32 5
2023/2024689 28 29 69 15 33 94 122 181 30 10 44 34
2024/20251.629 3 242 273 98 111 134 76 70 112 154 140 216
2025/20263.313 373 122 191 444 319 276 558 110 361 559 0 0
Totale 9.772